Purpose: The clinical course of patients diagnosed with non-small cell lung cancer (NSCLC) with brain metastases (BM) at presentation is variable. Here we seek to identify predictors of survival in patients staged with FDG-PET/CT.
American Association of Physicists in Medicine (AAPM) 52nd Annual Meeting July 18-22, Philadelphia, PA
Ohri, N.; Xiao, Y.; and Werner-Wasik, M.
"Predictors of Survival for Patients with Non-small Cell Lung Cancer and Synchronous Brain Metastases with FDG-PET/CT Staging,"
Bodine Journal: Vol. 3
, Article 15.
Available at: http://jdc.jefferson.edu/bodinejournal/vol3/iss1/15